Errata: B-Type Natriuretic Peptide Inhibits the Expression and Function of SERCA2a in Heart Failure.

IF 1.2 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

International heart journal Pub Date : 2024-01-01 DOI:10.1536/ihj.65-4_Errata

引用次数: 0

Abstract

Several errors (shown with underlines) in the following list appeared in the article "B-Type Natriuretic Peptide Inhibits the Expression and Function of SERCA2a in Heart Failure" by Yuting Zhai, Junhong Chen, Rongsheng Kan, Haochen Xuan, Chaofan Wang, Dongye Li, Tongda Xu (Vol. 65 No.2, 292-299, 2024).

查看原文本刊更多论文

勘误：B型钠尿肽抑制心力衰竭中SERCA2a的表达和功能

翟玉婷、陈俊红、阚荣生、宣浩辰、王超凡、李东烨、徐通达的文章《B 型钠尿肽抑制心力衰竭患者 SERCA2a 的表达和功能》（第 65 卷第 2 期，292-299，2024 年）中出现了以下错误（用下划线表示）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International heart journal 医学-心血管系统

CiteScore

2.50

自引率

6.70%

发文量

148

审稿时长

6-12 weeks

期刊介绍： Authors of research articles should disclose at the time of submission any financial arrangement they may have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, the editors will usually discuss with the authors the manner in which such information is to be communicated to the reader.